- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02063984
Behavioral Treatment of Adolescent Substance Use (SMART)
Behavioral Treatment of Adolescent Marijuana Use
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21229
- Mountain Manor Treatment Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Participants must be 12 to 26 years of age, must live at home with the parent who will participate, report using marijuana during the previous 30 days or provide a marijuana-positive urine test, meet criteria for cannabis abuse or dependence, and have a parent who can participate.
Exclusion Criteria: DSM criteria for dependence (likely to be adjusted for DSM-5 Use Disorder) on alcohol or other drugs other than marijuana (use of or meeting criteria for abuse of other substances will not be an exclusion criterion), active psychosis, severe medical or psychiatric illness limiting participation, or pregnant or breast-feeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensive Outpatient Treatment (IOP) + Contingency Management (CM) + Working Memory Training (WMT)
IOP + CM + WMT
|
Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives
25 computer-delivered sessions of neurocognitive training
Other Names:
|
|
Active Comparator: IOP + CM
|
Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Any Cannabis Abstinence
Time Frame: Intervention weeks 1 to 14
|
Number of participants with any cannabis abstinence during treatment
|
Intervention weeks 1 to 14
|
|
Weeks of Continuous Cannabis Abstinence
Time Frame: 14 week treatment period
|
Weeks of continuous abstinence during treatment
|
14 week treatment period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Any Days of Cannabis Use
Time Frame: Intervention weeks 1 to 14
|
Number of participants with any days of cannabis use during treatment
|
Intervention weeks 1 to 14
|
|
Days of Cannabis Use
Time Frame: The intervention period between Week 1 and Week 14
|
Percent of Days Used During the Treatment Period
|
The intervention period between Week 1 and Week 14
|
|
Any Cannabis Abstinence Across Four Treatment Strategies
Time Frame: Treatment period between week 1 and week 14
|
Number of participants who achieved at least one week of abstinence
|
Treatment period between week 1 and week 14
|
|
Weeks of Cannabis Abstinence Across Four Treatment Strategies
Time Frame: Treatment period between week 1 and week 14
|
Mean weeks of continuous cannabis abstinence among those who achieved at least one week of abstinence
|
Treatment period between week 1 and week 14
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Alan J Budney, Ph.D, Dartmouth College
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DA015186-DartmouthSpectrum
- R01DA015186-12A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
University of Illinois at ChicagoNot yet recruitingHealthy | Cannabis Use | Substance Use Disorder (SUD)United States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
Clinical Trials on Intensive Outpatient Treatment (IOP) + Contingency Management (CM)
-
Parnassia Addiction Research CentreAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Leiden University... and other collaboratorsRecruiting
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
VA Office of Research and DevelopmentActive, not recruitingPTSD | Cannabis-Related DisorderUnited States
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)Completed
-
NYU Langone HealthNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Oregon Social Learning CenterCompleted
-
UConn HealthNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DependenceUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedAdolescent Substance UseUnited States
-
University of OviedoCompleted